Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A CANCER UBIQUITOME LANDSCAPE IDENTIFIES METABOLIC REPROGRAMMING AS TARGET OF PARKIN TUMOR SUPPRESSION

ABSTRACT: SILAC-based Global Proteome and diGly antibody enrichment of PC3 Cells Expressing Parkin or Vector

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Dario C. Altieri

PROVIDER: MSV000087097 | MassIVE | Thu Mar 25 13:19:00 GMT 2021

SECONDARY ACCESSION(S): PXD025014

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

A cancer ubiquitome landscape identifies metabolic reprogramming as target of Parkin tumor suppression.

Project description: Not available

| S-EPMC8386929 | biostudies-literature

Loss-of-parkin function enhances cyclin D1 expression and AKT signalling and promotes glioblastoma cell proliferation

Project description:Mutations in the parkin gene, which encodes a ubiquitin ligase, are a major cause of autosomal recessive parkinsonism. Interestingly, parkin also plays a role in cancer as a putative tumor suppressor. Consistent with this, the gene is frequently targeted by deletion and inactivation in human malignant tumors. Here, we show that parkin expression is dramatically reduced in glioma cells, which correlates with increased cancer mortality. We further show that restoration of parkin expression in these cells promotes their arrest at G1 phase and significantly mitigates their proliferation rate both in vitro and in vivo. Notably, the level of cyclin D1, but not cyclin E, is reduced in parkin-expressing glioma cells. Moreover, parkin expression also leads to a selective downregulation of Akt serine-473 phosphorylation and VEGF receptor levels. Supporting this, cells derived from parkin null mouse exhibit increased levels of cyclin D1, VEGF receptor and Akt phosphorylation and divide significantly faster compared to their wild type counterparts. Importantly, analysis of parkin pathway activation revealed its predictive power for survival outcome of glioma patients. Taken together, our study provides a mechanism by which parkin exerts its tumor suppressor function and a signature pathway of parkin that is of potential prognostic value. Total RNA obtained from U-87MG cells stably expressing parkin or vector alone. Replicate arrays were performed for each of the 3 vector and parkin-expressing U-87MG clones.

2012-03-15 | E-GEOD-29494 | biostudies-arrayexpress

Deep sequencing of human fibroblastic cell line IMR90, either proliferating or senescent, expressing either empty vector or Parkin, with or without CCCP treatment

Project description:Gene expression changes were compared in proliferating and senescent human IMR90 cells, with either empty vector, Parkin, or Parkin+CCCP. Method: RNA was extracted, in triplicate, then sequenced with an Illumina NextSeq 500 sequencer. Sequence reads passing the quality control filters were aligned using Tophat2 and then analysed with Cufflinks.

2020-06-30 | GSE132369 | GEO

Oncogenic context shapes the fitness landscape of tumor suppression.

Project description: Not available

| S-EPMC10570323 | biostudies-literature

Parkin as a Tumor Suppressor Gene for Hepatocellular Carcinoma

Project description:To provide an insight into the molecular mechanism by which parkin deficiency contributes to hepatocarcinogenesis, we analyzed gene expression profiles of nontumorous and tumorous liver tissues from parkin–/– mice using cDNA microarray analyses. Keywords: genetic alteration

2007-11-30 | GSE9651 | GEO

Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma.

Project description: Not available

| S-EPMC7902673 | biostudies-literature

Suppression of glioblastoma by a drug cocktail reprogramming tumor cells into neuronal like cells.

Project description: Not available

| S-EPMC6401026 | biostudies-literature

Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice.

Project description: Not available

| S-EPMC6061949 | biostudies-literature

Reprogramming tumor immune microenvironment by milbemycin oxime results in pancreatic tumor growth suppression and enhanced anti-PD-1 efficacy.

Project description: Not available